SECTION III - SHOULD SEPARATE END-POINT TRIALS BE REQUIRED FOR ALL LIPID-LOWERING DRUGS ACTING BY THE SAME MECHANISM - PRESENTATION III

Authors
Citation
Fm. Sacks, SECTION III - SHOULD SEPARATE END-POINT TRIALS BE REQUIRED FOR ALL LIPID-LOWERING DRUGS ACTING BY THE SAME MECHANISM - PRESENTATION III, The American journal of cardiology, 81(8A), 1998, pp. 90-92
Citations number
7
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Cardiac & Cardiovascular System
ISSN journal
0002-9149
Volume
81
Issue
8A
Year of publication
1998
Pages
90 - 92
Database
ISI
SICI code
0002-9149(1998)81:8A<90:SI-SSE>2.0.ZU;2-T